Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tick Borne Encephalitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00460486
What this trial is testing

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 330
Post-approval studies (Phase 4)Study completedNCT00161954
What this trial is testing

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Not applicableStudy completedNCT05941546
What this trial is testing

Tick-borne Encephalitis Virus Research in Limousin

Who this might be right for
Tick-borne Encephalitis
University Hospital, Limoges 878
Not applicableLooking for participantsNCT07191223
What this trial is testing

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France

Who this might be right for
Tick-borne Encephalitis, France
University Hospital, Strasbourg, France 100
Not applicableUnknownNCT00941590
What this trial is testing

Postencephalitic Symptoms After Tick Borne Encephalitis

Who this might be right for
Central European Encephalitis
University Medical Centre Ljubljana 200
Testing effectiveness (Phase 2)Study completedNCT00161889
What this trial is testing

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 615
Post-approval studies (Phase 4)Study completedNCT00894686
What this trial is testing

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 179
Testing effectiveness (Phase 2)Study completedNCT00161798
What this trial is testing

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

Who this might be right for
Tick-borne Encephalitis
Pfizer
Not applicableUnknownNCT05607394
What this trial is testing

Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases

Who this might be right for
Tick-borne Encephalitis
University Hospital, Strasbourg, France 500
Large-scale testing (Phase 3)Study completedNCT01361776
What this trial is testing

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 200
Large-scale testing (Phase 3)Looking for participantsNCT07584525
What this trial is testing

Dexamethasone in Tick-borne Encephalitis

Who this might be right for
Tick-Borne Encephalitis
University Medical Centre Ljubljana 200
Post-approval studies (Phase 4)Study completedNCT02511535
What this trial is testing

TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients

Who this might be right for
Vaccine Responsiveness in AllergyVaccine Responsiveness During Allergy De-sensitization Treatment
Medical University of Vienna 119
Testing effectiveness (Phase 2)Study completedNCT01991067
What this trial is testing

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Who this might be right for
Tick Borne Encephalitis
Medical University of Vienna 34
Early research (Phase 1)Study completedNCT00118924
What this trial is testing

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Who this might be right for
Tick-Borne Encephalitis
National Institute of Allergy and Infectious Diseases (NIAID) 28
Testing effectiveness (Phase 2)UnknownNCT00890422
What this trial is testing

Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine

Who this might be right for
Tick Borne Encephalitis
Elisabethinen Hospital 99
Not applicableActive Not RecruitingNCT05138055
What this trial is testing

The NOrwegian Tick-borne Encephalitis Study

Who this might be right for
Tick-Borne Encephalitis, European
Sykehuset Telemark 153
Post-approval studies (Phase 4)Study completedNCT00311493
What this trial is testing

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Who this might be right for
Encephalitis, Tick-Borne
Novartis 179
Large-scale testing (Phase 3)Study completedNCT00161824
What this trial is testing

Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR

Who this might be right for
Encephalitis, Tick-borne
Pfizer 3,800
Testing effectiveness (Phase 2)Ended earlyNCT01031537
What this trial is testing

Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)

Who this might be right for
Tick-Borne EncephalitisEncephalitis, Tick-BorneTick-Borne Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 69
Not applicableUnknownNCT02463942
What this trial is testing

Tick-borne Encephalitis and Positive Borrelial Antibodies

Who this might be right for
Tick-borne Encephalitis
University Medical Centre Ljubljana 100
Next Page